Pharmaceutical Distributors directories

    Pharmaceutical Distributors by country

    Distribution is where most market-entry plans in the Middle East, Africa and South Asia succeed or stall, and it is the layer least visible in public data. This hub collects the BioNixus pharmaceutical distributor directories so a channel team can see, country by country, who holds the import licence, who runs the wholesale depots, which public buyer consolidates hospital demand and which logistics providers move cold-chain product.

    Each country page classifies participants by role — licensed agents and importers, wholesalers, pharmacy chains with central purchasing, government procurement bodies and third-party logistics providers — and explains the channel path from registration to the hospital pharmacy or retail counter. The pages sit alongside the pharmaceutical company, pharmacy chain and hospital group directories for the same country so the manufacturer, intermediary and end-account layers can be read together.

    Coverage began with the Gulf states, Egypt, Iraq, Jordan, Morocco, Turkey and Pakistan, where agent selection and tender access are the questions BioNixus is briefed on most often. Priority markets in South Asia, Africa, Latin America and South-East Asia follow in later releases.

    Browse the directoriesSee how teams use them

    12

    directories in this hub

    12

    countries covered

    1

    company types

    48h

    to a scoped proposal

    Pharmaceutical Distributors

    Pharmaceutical Distributors by country

    Every pharmaceutical distributor directory BioNixus maintains, grouped by region. Each page carries 12–25 named accounts, the wholesalers, importers & 3pl layer, growth drivers and a country proposal form.

    GCC

    BahrainPharmaceutical Distributors in BahrainKuwaitPharmaceutical Distributors in KuwaitOmanPharmaceutical Distributors in OmanQatarPharmaceutical Distributors in QatarSaudi ArabiaPharmaceutical Distributors in Saudi ArabiaUnited Arab EmiratesPharmaceutical Distributors in the UAE

    Wider MENA & Turkey

    EgyptPharmaceutical Distributors in EgyptIraqPharmaceutical Distributors in IraqJordanPharmaceutical Distributors in JordanMoroccoPharmaceutical Distributors in MoroccoTurkeyPharmaceutical Distributors in Turkey

    Asia-Pacific

    PakistanPharmaceutical Distributors in Pakistan

    Who this is for

    What these directories are for

    Agent and importer selection

    Shortlist licensed distributors by portfolio fit, tender record and cold-chain capacity before appointing an exclusive agent in a new country.

    Tender and public-buyer mapping

    Understand which body pools public hospital demand — NUPCO, UPA, Kimadia, JPD, DMO and their peers — and which distributors win its awards.

    Channel performance audits

    Commission share-of-wholesaler, stock-availability and service-level studies at hospital and retail pharmacies to check how an appointed distributor performs.

    Questions

    Frequently Asked Questions

    What is the difference between a distributor directory and a pharmaceutical company directory?

    Distributor pages list the intermediaries — agents, wholesalers, public procurement bodies, pharmacy chains buying centrally and logistics providers. Pharmaceutical company pages list the manufacturers and brand owners. The two are kept separate so a search for a channel partner is not answered with a manufacturer list.

    Why are government bodies listed among distributors?

    In most of the covered markets a single public procurement agency buys the majority of hospital medicines and sets reference prices, so it is the most important channel account in the country and belongs on the map.

    How does BioNixus verify distributor coverage and performance?

    Through pharmacy purchase-record audits, hospital pharmacist and procurement interviews, tender-award tracking and mystery-shopper availability checks in the main cities of each country.

    Which countries will be added next?

    India, China, Brazil, Mexico, South Africa, Nigeria, Indonesia and Vietnam are scheduled once BioNixus fieldwork in those channels reaches the depth needed to classify distributors with confidence.

    48-hour proposal

    Need account-level data on any of these companies?

    Tell us the market, the accounts and the decision. BioNixus scopes a primary-research proposal within 48 hours.

    Planning research in Global?

    Primary research, market access & HEOR. Proposals within 48 hours.